tm
Seeing Is Believing
tm
Seeing Is Believing
Aeglea Bio Therapeutics's activity chart (see below) currently has 18 price targets and 27 ratings on display.
Analysts average stock forecasts to be materialized ratio is 53.57% with an average time for these price targets to be met of 69.71 days.
Most recent stock forecast was given by from WELLS FARGO on 13-Nov-2023. First documented stock forecast 09-May-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Aug-2023
$12
$-15.6 (-56.52%)
$12.5
2 years 7 months 26 days ago
(13-Nov-2023)
2/2 (100%)
$1.82 (17.88%)
10
Buy Since 25-Jul-2023
$23
$-4.6 (-16.67%)
$22.5
2 years 8 months 16 days ago
(23-Oct-2023)
2/2 (100%)
$10.59 (85.33%)
120
Hold Since 03-Mar-2023
3 years 4 months 6 days ago
(03-Mar-2023)
0/3 (0%)
$161.25 (75.44%)
Buy Since 27-Oct-2022
$25
3 years 8 months 12 days ago
(27-Oct-2022)
1/4 (25%)
$6.75 (36.99%)
151
Buy Since 04-Feb-2022
4 years 1 months 6 days ago
(03-Jun-2022)
3/3 (100%)
$-30.5 (-77.22%)
161
What is AGLE (Aeglea Bio Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AGLE (Aeglea Bio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most bullish on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most reserved on AGLE (Aeglea Bio Therapeutics)?
